Last reviewed · How we verify

NCT04942457: KiWuA

Feasibility and Safety of Fasting in Fertility Treatment

Completed NA Last updated 29 December 2023
What this trial tests

NA trial testing Fasting in Sub Fertility, Female in 34 participants. Completed in 20 December 2023.

Timeline
10 January 2022
Primary endpoint
20 December 2023
20 December 2023

Quick facts

Lead sponsorCharite University, Berlin, Germany
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment34
Start date10 January 2022
Primary completion20 December 2023
Estimated completion20 December 2023
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Charite University, Berlin, Germany

Who can join

Adults 25 to 45, female only, with Sub Fertility, Female or Fertility Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This exploratory study investigates fasting as a potential supportive therapy in infertility treatment for women suffering from infertility

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Fasting

Trials testing the same drug.

Other Charite University, Berlin, Germany trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04942457.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing